Featured Research

from universities, journals, and other organizations

WHO Panel Recommends Single, Simple Test For New TB Vaccine Trials

Date:
June 30, 2008
Source:
Public Library of Science
Summary:
The World Health Organization Initiative for Vaccine Research recently convened a panel of TB vaccine trial experts to examine the best way of testing immunity in blood taken from people vaccinated with a new TB vaccine. Phase three trials focus on testing whether the vaccines will work to protect people against TB.

The World Health Organization Initiative for Vaccine Research recently convened a panel of TB vaccine trial experts to examine the best way of testing immunity in blood taken from people vaccinated with a new TB vaccine.

Related Articles


"The panel recognised that many new and diverse tuberculosis vaccines are currently under development," says the lead author Professor Hanekom, of the South African TB Vaccine Initiative. "The ability to compare results of how the immune systems of people who received these vaccines have responded would be an important asset for TB vaccine research globally." Previously, it has been difficult to compare results because of differences in laboratory approaches, logistics and diverse populations being tested.

The panel evaluated advantages and disadvantages of many types of immune tests, and made specific recommendations for human trials of new vaccines, which included introducing a single and simple test that is used in all vaccine trials.

"The panel recommended the use of a test that had performed excellently, that could yield informative results, and that could be implemented in even the most remote of field sites," says Professor Hanekom. "It is anticipated that this single and simple test will speed up decision-making on which of the new TB vaccines currently being tested globally will proceed to phase three trials."

Phase three trials focus on testing whether the vaccines will work to protect people against TB. The single and simple test recommended by the panel would allow comparison of results on the human immune response to all new TB vaccines currently being tested by the many research initiatives globally. If implemented, this could shorten the process to find an effective vaccine against TB.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hanekom et al. Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations. PLoS Medicine, 2008; 5 (7): e145 DOI: 10.1371/journal.pmed.0050145

Cite This Page:

Public Library of Science. "WHO Panel Recommends Single, Simple Test For New TB Vaccine Trials." ScienceDaily. ScienceDaily, 30 June 2008. <www.sciencedaily.com/releases/2008/06/080630201004.htm>.
Public Library of Science. (2008, June 30). WHO Panel Recommends Single, Simple Test For New TB Vaccine Trials. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2008/06/080630201004.htm
Public Library of Science. "WHO Panel Recommends Single, Simple Test For New TB Vaccine Trials." ScienceDaily. www.sciencedaily.com/releases/2008/06/080630201004.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins